3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
To Study Immunostatus of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT
1
Thyroid Carcinoma, Anaplastic
1
Radiation Injuries
1
Prostatic Neoplasms
1
Prostatic Hyperplasia
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neurofibromatosis 1
1
Neoplasms
1
Lung Neoplasms
1
Locally Advanced Non Small Cell Lung Cancer
1
Liver Cirrhosis
1
Hematologic Neoplasms
1
HIV Infected Patients With Cancer Treated by ICPi
1
Glioma
1
Fallopian Tube Neoplasms
1
Cystadenocarcinoma, Serous
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Urination
1
Transurethral Resection of Prostate
1
Magnetic Resonance Spectroscopy
1
Finasteride
1
Dutasteride
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Prostatic Hyperplasia
×
Blood Specimen Collection
×
Clear all
NCT06116851
2023-11-03
PROMIC
Turku University Hospital
Recruiting
300 enrolled